Vesicular monoamine transporters: Structure-function, pharmacology, and medicinal chemistry

A Molecular Glimpse of Vesicular Monoamine Transporters

(2010) Shimon Schuldiner   JOURNAL OF NEUROCHEMISTRY

Novel hypoglycemic dihydropyridones serendipitously discovered from O- versus C-alkylation in the synthesis of VMAT2 antagonists

(2008) Yuli Xie et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Methylphenidate for the Treatment of Parkinson Disease and Other Neurological Disorders

(2008) Eitan Auriel et al.   CLINICAL NEUROPHARMACOLOGY

Vesicular Monoamine Transporter Substrate/Inhibitor Activity of MPTP/MPP+Derivatives: A Structure–Activity Study

(2008) D. Shyamali Wimalasena et al.   JOURNAL OF MEDICINAL CHEMISTRY

In Vivo Imaging of  -Cell Mass in Rats Using 18F-FP-(+)-DTBZ: A Potential PET Ligand for Studying Diabetes Mellitus

(2008) M.-P. Kung et al.   JOURNAL OF NUCLEAR MEDICINE

Association between Polymorphisms in the Vesicular Monoamine Transporter 1 Gene (VMAT1/SLC18A1) on Chromosome 8p and Schizophrenia

(2008) Falk W. Lohoff et al.   NEUROPSYCHOBIOLOGY

Association between variation in the vesicular monoamine transporter 1 gene on chromosome 8p and anxiety-related personality traits

(2008) Falk W. Lohoff et al.   NEUROSCIENCE LETTERS

In vivo imaging of vesicular monoamine transporter 2 in pancreas using an 18F epoxide derivative of tetrabenazine

(2008) Hank F. Kung et al.   NUCLEAR MEDICINE AND BIOLOGY

Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat

(2008) W.-S. Choi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Dopamine modulating drugs influence striatal (+)-[11C]DTBZ binding in rats: VMAT2 binding is sensitive to changes in vesicular dopamine concentration

(2008) Junchao Tong et al.   SYNAPSE

Methamphetamine Rapidly Decreases Vesicular Dopamine Uptake

(2003) Jeffrey M. Brown et al.   JOURNAL OF NEUROCHEMISTRY